<!DOCTYPE HTML>
<html>
  <head>
    <meta http-equiv="Content-type" content="text/html;" >
	<title>Prazosin</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Prazosin</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Minipres</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial dose for nightmares in mTBI = 1mg QHS for 3 days </li>
						<li>May increase to 2mg QHS through day 7 </li>
						<li>If patient continues to have nightmares, the dosage may be increased to 4mg QHS through day 14 </li>
						<li>The dosage could be increased to 6mg QHS through day 21 and to 10mg QHS through day 28 </li>
						<li>The maximum daily nightmare dose =  10mg QHS.</li>
						<li>Initial Sympatholytic dose in PTSD = 1mg QHS </li>
						<li>May increase dose as blood pressure allows</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Consider prazosin to  augment the management of nightmares and other symptoms of PTSD</li>
						<li>Primarily used for management  of recurrent distressing dreams and/ or violent outbursts oragitation during sleep</li> 
					</ul> 
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Adverse Effect: orthostatic hypotension, dizziness, headache, nausea and palpitations </li>
						<li>May cause day time sedation </li>
						<li>Associated with first-dose effect orthostatic hypotension or syncope; This can occur with the first few doses, upon rapid increases in dose or if another antihypertensive is added; Effect may be minimized by beginning initial dose with 1mg Qhs and slowly increasing the  dose</li>
						<li>Not recommended in hypotension or dizziness. </li>
						<li>Rare reports of priapism have ccurred</li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margins</h3>	
					<ul>
						<li>Serious toxicity with overdose </li>
						<li>Avoid concurrent use with alcohol</li>
					</ul>
<hr>
					<h3>Efficacy</h3>	
					<ul>
						<li>Open trials and clinical experience suggest it may be useful for ASR; However, this has not been  systematicallystudied</li> 
						<li>In four relatively  small studies prazosin hasdemonstrated a value in reducing nightmares and in improving  Clinician- Administered PTSD Scale(CAPS), CGI, and CGIC  scores</li>
						<li>Prazosin has a fair overall quality of evidence for use in PTSD</li>					
					</ul>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
